Registry data as of Aug 27, 2026

Amar Bhat, M.D.

Cornea and External Diseases Specialist Physician · Houston, TX

Amar Bhat, M.D. is a cornea and external diseases specialist physician with a practice address in Houston, Texas, and NPI 1427443514, issued on Apr 6, 2015. Check the license (Texas S4601, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, loaded Aug 27, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordas of Aug 27, 2026
1427443514
Name
Amar Bhat
Credential
M.D.
Primary taxonomy
Cornea and External Diseases Specialist Physician 207WX0120X
License number
S4601 TX
Self-reported in NPPES; status is on the state search
Practice location
10130 Grant RD Ste 212, Houston, TX 77070
Phone
(346) 776-2020
Enumerated
Apr 6, 2015
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Verify Amar Bhat in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license S4601
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

33% more Medicare Part D claims than the average cornea and external diseases specialist physician in 2024

1,736 Medicare Part D claims for 529 beneficiaries, against an average of 1,306 among the 282 providers of this specialty who prescribed in Part D. Brand-name drugs were 39% of claims.

  1. Amar Bhat1,736
  2. Specialty average1,306

Most prescribed

  1. Latanoprost322 claims
  2. Erythromycin213 claims
  3. Prednisolone Acetate207 claims
  4. Moxifloxacin156 claims
  5. Timolol Maleate124 claims
  6. Neomycin-Polymyxin-Dexameth62 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's Medicare quality score for 2023: 90.2 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score100.0
  2. Costout of 100 · 30%67.3
  3. Promoting interoperabilityout of 100 · 25%
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $431.24

17 payments, mostly food and beverage; the largest payer was Abbvie Inc.. The 247 providers of this specialty with any payment received $3,865.64 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Amar Bhat$431.24
  2. Specialty average$3,865.64

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

One hospital or facility affiliation

  1. Modern Eye PLLCHouston, TX

Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.

Cornea and External Diseases Specialist Physician providers in Texas

There are 28 cornea and external diseases specialist physician records in Texas.

Other cornea and external diseases specialist physician records in Texas

  1. Alejandro ArboledaHouston, TX1881153609
  2. Walter Beebe, MDDallas, TX1093742207
  3. Paramjit Bhullar, MDJbsa Lackland, TX1003348046
  4. Andrew Bowman, MDPlano, TX1699279133
  5. Charles Bowman, MDDallas, TX1457397762
  6. Jay Bradley, M.D.Lubbock, TX1912042763
  7. Ashley Brundrett, M.D.Round Rock, TX1841630639
  8. Jimena Camp, M.DSan Antonio, TX1821478355
  9. Jordan ComstockDallas, TX1619465374
  10. Thomas Dietze, M.D.Corpus Christi, TX1417938713

Common questions

What is Amar Bhat, M.D.'s NPI number?

Amar Bhat, M.D.'s National Provider Identifier (NPI) is 1427443514, issued on Apr 6, 2015. An NPI identifies a provider in billing; it is not a license.

Where is Amar Bhat, M.D. located?

The NPPES record lists a practice address at 10130 Grant RD Ste 212, Houston, TX, 77070. Phone: (346) 776-2020. Providers update this record themselves, so call before visiting.

How can I verify Amar Bhat, M.D.'s license?

NPPES lists Texas license number S4601, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Amar Bhat, M.D. prescribe under Medicare Part D?

In 2024, Amar Bhat, M.D. had 1,736 Medicare Part D claims for 529 beneficiaries; the average among cornea and external diseases specialist physician prescribers was 1,306. Part D covers Medicare prescriptions only.

What is Amar Bhat, M.D.'s Medicare quality score?

The 2023 MIPS final score is 90.2 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.